-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
December 14, 2017 - Serious adverse events attributed to BT were
infrequent, and no deaths were reported.” … Serious adverse events attributed to BT were
infrequent, and no deaths were reported.”
4 As evidenced … ).18Serious adverse
events attributed to BT occurred during
the 12-week treatment period, and no
deaths … 47
Commentator &
Affiliation Section Comment Response
the 12-week treatment period, and no
deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary
Comparative Effectiveness Review
Number 230
Therapies for Clinically
Localized Prostate Cancer
Evidence Summary
Main Points
• In men with clinically localized prostate cancer (CLPC) detected clinically rather than
by prostate-speci…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
October 05, 2015 - (severe and even fatal side effects,15 with estimates of 50 to 150
seclusion- or restraint-related deaths … frequency of use as an indicator of quality of care.50 The Joint Commission reported in
2010 more than 200 deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
July 06, 2015 - Conclusions are probably not current due to findings
indicating that ARB may relate to an increase in CV deaths … 7 may probably
not be current due to findings indicating that ARB may relate to an increase in CV deaths … Conclusions are probably not be current due to findings indicating that ARB
may relate to an increase in CV deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - valid and this
portion of the
original report
does not need
updating
Ginkgo biloba
With no deaths … New Evidence:
Ginkgo biloba
With no deaths observed, insufficient evidence for mortality
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-failure-rescue-protocol-amendment.pdf
September 19, 2023 - Antecedents to hospital deaths.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
September 01, 2016 - Comparing Talk Therapy and Other Depression Treatments With Antidepressant Medicines
Comparing Talk Therapy and
Other Depression Treatments
With Antidepressant Medicines
A Review of the Research for Adults
e
Is This Information Right for Me?
This information is right for you if:
�Your health care professional…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
August 01, 2016 - Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN
Focus of This Summary
This is a summary of two systematic reviews. One review evaluated the evidence regarding the comparative effects of
different contrast media in patients requiring diagnostic imaging studies…
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - million healthcare-acquired infections (HAIs) are documented
in the U.S. annually and result in 100,000 deaths … 12 (heterogeneity p = 0.50 vs 13-40 days), driven by 7
(1.2%) fidaxomicin vs 17 (2.9%) vancomycin deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-education-protocol.pdf
January 01, 2018 - asthma, and in 2016
asthma accounted for 1.7 million emergency department visits and more than 3,500
deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - Suicide-related SGA vs. placebo (7 RCTs) Moderate No significant difference for suicide-related
behaviors deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-bias_methods.pdf
July 01, 2012 - Methods Guide for Medical Test Reviews
5-1
Chapter 5
Assessing Risk of Bias as a Domain of Quality in
Medical Test Studies
P. Lina Santaguida, B.Sc.P.T., Ph.D., M.Sc., McMaster University
Crystal M. Riley, M.A., Nanyang Technological University, Singapore
David B. Matchar, M.D., Duke University;
Duke-…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
May 01, 2013 - found that
suicide was the leading cause of maternal mortality, accounting for 29 percent of maternal
deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
August 10, 2016 - Cutaneous squamous cell carcinoma:
estimated incidence of disease, nodal
metastasis, and deaths from
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
August 08, 2017 - Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E
Appendix E. Study Char
Appendix E. Study Characteristics Evidence Tables
E-1. NPP
Table E-1. Neuropathic Pain
Author, Year
Country
Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Random…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
May 22, 2012 - Evidence-based Practice Center Systematic Review Protocol
EPC Protocol Version 11 Page 1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Treatment of Atrial Fibrillation
Amendment Date(s):
Amendment 1 - May 22, 2012 (see Section VII for details)
I. Background and Obje…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_disposition-comments.pdf
October 23, 2012 - Disposition of Comments Report for Comparison of Characteristics of Nursing Homes and Other Residential Long-Term Care Settings for People With Dementia
Source: http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?productid=1293&pageaction=displayproduct
Published Online: October …
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - ORIGINAL ARTICLE
Assessment of Adherence to and Persistence on
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Patients With Rheumatoid Arthritis
Carlos G. Grijalva, MD, MPH,* Cecilia P. Chung, MD, MPH,† Patrick G. Arbogast, PhD,*‡
Charles M. Stein, MD,† Edward F. Mitchel, Jr, MS,* and Marie R. Griffin, MD, MPH*§¶…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendices.pdf
January 01, 2025 - crosses
threshold of
5/1,000 for
outcome of
“death”; rare
events)
None At 3 years followup, 2
deaths … Calculated ARD per
1,000, 183 fewer; 95%
CI, from 273 fewer to 19
fewer
Serious adverse
events (deaths … thresholds, 5/1,000
& -5/1,000, for
outcome of “death”;
rare events)
None At 5 years followup,
only 2 deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
December 06, 2016 - drugs in the U.S. has
contributed to avoidable HIV and hepatitis infections,
in addition to countless deaths … There is much
confusion about the role of buprenorphine in overdose
deaths and about its potential … prescribing and misuse of this medication resulted in
a significant number of unintentional overdose deaths